when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Moderna, Inc. ($MRNA) · news · pharmadog

← back to Moderna, Inc.

News mentioning $MRNA

171 stories

Aug 6, 26STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and morestat

Aug 6, 26Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasstat

Aug 6, 26Covid can reactivate dormant viruses, according to studystat

Aug 6, 26Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblockbiospace

Aug 6, 26FDA approves Moderna’s mRNA flu vaccinebiopharma dive

Aug 6, 26FDA approves Moderna’s mRNA flu vaccine, the first to use the technologystat

Aug 6, 26Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMSraps

Aug 5, 26STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatmentsstat

Aug 5, 26STAT+: Could poop pills be the next treatment for food allergies?stat

Aug 5, 26STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safetystat

Aug 5, 26STAT+: Moderna launches early trial of Ebola mRNA vaccinestat

Aug 5, 26STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and morestat

Aug 5, 26The main therapy used for children with autism faces changes under Medicaidstat

Aug 4, 26BioNTech cuts sales forecast on slumping demand for COVID-19 vaccinebiospace

Aug 4, 26Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructurebiospace

Aug 3, 26BioNTech taps Sobi executive Oelkers as its next CEObiopharma dive

Aug 3, 26STAT+: Is there a pharma mega-merger in the making?stat

Aug 3, 26BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechbiospace

Aug 3, 26STAT+: BioNTech names Guido Oelkers its new CEOstat

Aug 3, 26After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech

Jul 31, 26Moderna maintains 10% growth target despite Phase 3 norovirus missbiospace

Jul 30, 26J&J secures right to take the helm in up to $925M Sail CAR T pactbiospace

Jul 30, 26Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the storebiospace

Jul 27, 26FDA has recommitted to adcomms—but to what end?biospace

Jul 23, 26FDA panel confronting peptide controversystat

Jul 22, 266 companies hiring in Cambridge nowbiospace

Jul 20, 26Opinion: It’s time to treat pandemics as threats to national securitystat

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 16, 26Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsendpoints

← prevpage 5 of 6next →